학술논문

Remibrutinib (LOU064) inhibits neuroinflammation driven by B cells and myeloid cells in preclinical models of multiple sclerosis
Document Type
Article
Source
In: Journal of Neuroinflammation. (Journal of Neuroinflammation, December 2023, 20(1))
Subject
Language
English
ISSN
17422094